CRISPR Therapeutics AG (CRSP) Tax Provisions (2015 - 2026)

CRISPR Therapeutics AG has disclosed Tax Provisions across 12 years of filings, most recently posting $1.0 million for Q2 2026.

• In Q2 2026, Tax Provisions fell 23.08% year-over-year to $1.0 million; the TTM figure through Jun 2026 stood at $3.1 million (down 31.43% YoY), while the FY2025 annual figure was $3.6 million, down 10.73% from the prior year.
• Tax Provisions came in at $1.0 million for Q2 2026 at CRISPR Therapeutics AG, up from $839000.0 in the prior quarter.
• In the past five years, Tax Provisions ranged from a high of $6.1 million in Q2 2022 to a low of -$8.5 million in Q4 2022.
• Average Tax Provisions over 5 years is $747444.4, with a median of $911500.0 recorded in 2023.
• The largest YoY upside for Tax Provisions was 501.33% in 2022 against a maximum downside of 277.94% in 2022.
• Over 5 years, Tax Provisions stood at -$8.5 million in 2022, then jumped by 107.19% to $612000.0 in 2023, then jumped by 91.34% to $1.2 million in 2024, then slumped by 47.57% to $614000.0 in 2025, then surged by 62.87% to $1.0 million in 2026.
• Per Business Quant data, the three most recent Tax Provisions figures were $1.0 million in Q2 2026, $839000.0 in Q1 2026, and $614000.0 in Q4 2025.